Altius Strategy Consulting


Reaching higher goals in healthcare

 

Altius Strategy Consulting helps companies plan for successful pricing, reimbursement, market access and adoption of medical products through the creation and demonstration of product value. 


Altius specializes in a multidisciplinary approach to product analyses that integrates scientific, clinical, regulatory, health economic, health-related quality of life, and market information. 


Altius works closely with its clients’ senior teams, providing insights and advice to inform product and service development decisions.


Altius understands the increasingly demanding evidence requirements of market stakeholders. It incorporates this understanding into its strategic assessments, creating effective commercialization strategies and value development plans for products in late preclinical and clinical development.



ALTIUS IS THE LATIN WORD FOR HIGHER


Altius Strategy Consulting helps its clients attain higher goals in addressing

critical unmet medical needs through product Value Development Planning.

News / Events:


July 14, 2017 eyeforpharma interviews Altius Principal, Leora Schiff for its article, Trends in Value-Based Contracting


June 19-22, 2017 Altius attends the 2017 BIO International Convention and Partnering


June 3-6, 2017 Altius attends the ASCO 2017 Annual Meeting


June 2, 2017 Altius attends the Sachs 3rd Annual Immuno-Oncology BD&L and Investment Forum


May 31, 2017 Timmerman Report publishes interview by Altius Principal, Leora Schiff with outgoing Genzyme Sanofi CEO, David Meeker













© Altius Strategy Consulting 2017